Skip to content

In the BioHarmony Drug Report Database

Poractant alfa

Curosurf (poractant alfa) is an unknown pharmaceutical. Poractant alfa was first approved as Curosurf on 1999-11-18. It is used to treat newborn respiratory distress syndrome in the USA.
Trade Name Curosurf
Common Name Poractant alfa
Indication newborn respiratory distress syndrome
Drug Class Pulmonary surfactants; tachykinin (neurokinin) receptor antagonists
Poractant alfa
Get full access now